China says one billion COVID-19 vaccine dosages administered Kumar Jeetendra | June 21, 2021 China said on June 20 that it has administered over one billion doses of COVID-19 vaccines in the country. China has accelerated its pace of free COVID-19 vaccinations for the whole nation since late March and administered a billion doses by June 19, the National Health Commission (NHC) said. The NHC, however, did not say …
Cadila Pharma launches Posaconazole for treatment of fungal diseases Kumar Jeetendra | June 21, 2021 21 June 2021, Ahmedabad: Pharma major Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole, which has been found to be effective against a wide range of invasive fungal diseases. The drug has also been recommended as a second-line treatment for Mucormycosis or black fungus as it is commonly known. Posaconazole is approved for …
We didn’t back multiplying of vaccine dosing gap: Indian researchers Kumar Jeetendra | June 16, 2021 The Indian government doubled the gap between the two doses of the AstraZeneca COVID-19 vaccine without the agreement of the scientific group that it said recommended the increase, three members of the advisory body told Reuters. The ministry of health announced the decision to change the gap from 6-8 weeks to 12-16 weeks on May …
Pfizer, AstraZeneca vaccines secure against Delta variant: Lancet study Kumar Jeetendra | June 15, 2021 The Delta variant of coronavirus, first identified in India, doubles the risk of hospitalisation compared with the Alpha variant first found in the UK, but Pfizer and AstraZeneca vaccines provide good protection against the strain, says a study published in The Lancet journal. Researchers at Public Health Scotland and the University of Edinburgh, UK, found …
Zydus Cadila gets USFDA conditional gesture for epilepsy treatment drug Kumar Jeetendra | June 14, 2021 New Delhi: Zydus Cadila on Monday said it has received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets. Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a …
Natco Pharma’s promoting accomplice gets USFDA gesture for anti cancer drug Kumar Jeetendra | June 14, 2021 New Delhi, Jun 14 (PTI) Natco Pharma on Monday said its marketing partner Breckenridge Pharmaceutical Inc has received approval from the US health regulator for anti-cancer drug Carfilzomib Vials. “Breckenridge Pharmaceutical Inc. (BPI), has received approval for its abbreviated new drug application (ANDA) for Carfilzomib Vials ANDA (generic for Kyprolis), from the US Food and …
Brazil endorses Pfizer COVID-19 antibody for kids more than 12 Kumar Jeetendra | June 11, 2021 Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age. Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group. The vaccine, the first in Brazil to receive definitive approval from …
India near offering reimbursement to foreign vaccine creators like Pfizer: Report Kumar Jeetendra | June 10, 2021 India is close to agreeing to grant foreign COVID-19 vaccine makers such as Pfizer Inc protection against legal liability so that it can use their shots in an immunisation campaign that is facing acute shortages, three government sources told Reuters. “Indemnity will be granted,” said one of the sources. “If one company gets it then …
AstraZeneca COVID-19 immunization connected with little risk of low blood platelets: Study Kumar Jeetendra | June 10, 2021 The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK. The increased risk of the condition, known as idiopathic thrombocytopenic purpura (ITP), is estimated to be 11 per million doses, similar …
Rockwell Industries ties with DRL for freezer to store Sputnik V Kumar Jeetendra | June 9, 2021 Rockwell Industries, a cold chain appliance manufacturer on Wednesday announced its strategic partnership with Dr Reddy’s Labs, to provide its World Health Organisation – Performance, Quality and Safety certified Covid-19 vaccine freezersto enablestorage of Sputnik V vaccine in India. According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety …
Pfizer jab endorsed for kids, yet first others should be vaccinated Kumar Jeetendra | June 5, 2021 Moderna and Pfizer have released data suggesting that their vaccines are well tolerated in adolescents and highly effective in preventing COVID-19. Canada, the US and the EU have already authorised the Pfizer vaccine in children as young as 12. And the UK has just approved the use of the Pfizer vaccine in children aged 12 …
Pfizer jabs delivers less antibodies against Delta variation of Covid: Lancet study Kumar Jeetendra | June 4, 2021 People fully vaccinated with the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal. The study also shows that levels of these antibodies that are able to recognise …
